South & Central America Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, and Others); Route of Administration (Oral, and Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, and Others); and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        South and Central America Gastrointestinal Drugs Market – By Drug Class

1.3.2        South and Central America Gastrointestinal Drugs Market – By Route of Administration

1.3.3        South and Central America Gastrointestinal Drugs Market – By Application

1.3.4        South and Central America Gastrointestinal drugs Market – By Distribution Channel

1.3.5        South and Central America Gastrointestinal drugs Market – By Country

2.          South and Central America Gastrointestinal Drugs Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          South and Central America Gastrointestinal Drugs Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Gastrointestinal Drugs Market - South and Central America PEST Analysis

4.3        Expert Opinion

5.          South and Central America Gastrointestinal Drugs Market - Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Rise in Prevalence of Gastrointestinal (GI) Diseases

5.1.2        Increase in Development of Biologics

5.2        Market Restraints

5.2.1        Side Effects Associated with The Drugs

5.3        Market Opportunities

5.3.1        Increasing Investment in Research Activities and Growing Pipeline of GI Candidates

5.4        Future Trends

5.4.1        Emergence of Biosimilars

5.5        Impact Analysis

6.          Gastrointestinal Drugs Market – South and Central America Analysis

6.1        South and Central America Gastrointestinal Drugs Market Revenue Forecasts and Analysis

7.          South and Central America Gastrointestinal Drugs Market Analysis And Forecasts To 2027 – By Drug Class

7.1        Overview

7.2        South and Central America Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)

7.2.1        South and Central America Gastrointestinal drugs Market Revenue and Forecasts to 2027, By Drug Class (US$ Mn)

7.3        Acid Neutralizers

7.3.1        Overview

7.3.2        South and Central America Acid Neutralizers Market Revenue and Forecast to 2027 (US$ Mn)

7.4        Antidiarrheal and Laxatives

7.4.1        Overview

7.4.2        South and Central America Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)

7.5        Anti-Inflammatory Drugs

7.5.1        Overview

7.5.2        South and Central America Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

7.6        Antiemetic and Antinauseants

7.6.1        Overview

7.6.2        South and Central America Antiemetic and Antinauseants Market Revenue and Forecast to 2027 (US$ Mn)

7.7        Biologics

7.7.1        Overview

7.7.2        South and Central America Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

7.8        Others

7.8.1        Overview

7.8.2        South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.          South and Central America Gastrointestinal Drugs Market Analysis – By Route of Administration

8.1        Overview

8.2        South and Central America Gastrointestinal Drugs Market, By Route of Administration 2019-2027 (%)

8.2.1        South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)

8.3        Oral

8.3.1        Overview

8.3.2        South and Central America Oral Market Revenue and Forecasts to 2027 (US$ Mn)

8.4        Parenteral

8.4.1        Overview

8.4.2        South and Central America Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

9.          South and Central America Gastrointestinal Drugs Market Analysis – By Application

9.1        Overview

9.2        South and Central America Gastrointestinal Drugs Market, By Application 2019-2027 (%)

9.2.1        South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Application (US$ Mn)

9.3        Inflammatory Ulcerative Colitis

9.3.1        Overview

9.3.2        South and Central America Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)

9.4        Crohn's Disease

9.4.1        Overview

9.4.2        South and Central America Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

9.5        Irritable Bowel Syndrome

9.5.1        Overview

9.5.2        South and Central America Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)

9.6        Gastroenteritis

9.6.1        Overview

9.6.2        South and Central America Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)

9.7        Celiac Disease

9.7.1        Overview

9.7.2        South and Central America Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)

9.8        Others

9.8.1        Overview

9.8.2        South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.       South and Central America Gastrointestinal Drugs Market Analysis – By Distribution Channel

10.1      Overview

10.2      South and Central America Gastrointestinal Drugs Market, By Distribution Channel 2019-2027 (%)

10.2.1     South and Central America Gastrointestinal Drugs Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3      Hospital Pharmacies

10.3.1     Overview

10.3.2     South and Central America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.4      Retail Pharmacies

10.4.1     Overview

10.4.2     South and Central America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

10.5      Online Pharmacies

10.5.1     Overview

10.5.2     South and Central America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

11.       Gastrointestinal Drugs Market Revenue and Forecasts To 2027 – Geographical Analysis

11.1      South and Central America Gastrointestinal Drugs Market Revenue and Forecasts To 2027

11.1.1     Overview

11.1.2     South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)

11.1.3     South and Central America: Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

11.1.4     South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.5     South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.6     South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.7     South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

11.1.8     Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1       Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2       Brazil: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

11.1.8.3       Brazil: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.8.4       Brazil: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.8.5       Brazil: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.9     Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1       Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2       Argentina: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

11.1.9.3       Argentina: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.9.4       Argentina: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.9.5       Argentina: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.10   Rest of South and Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1    Rest of South and Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2    Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

11.1.10.3    Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

11.1.10.4    Rest of South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.1.10.5    Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

12.       Impact of COVID-19 Pandemic on South and Central America Gastrointestinal Drugs Market

12.1      South and Central America: Impact Assessment of COVID-19 Pandemic

13.       Company Profiles

13.1      Takeda Pharmaceutical Company Limited

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Celltrion Healthcare Co.,Ltd.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      AstraZeneca

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.       Appendix

14.1      Glossary of Terms

LIST OF TABLES

Table 1.            South and Central America Gastrointestinal drugs Market Revenue and Forecasts To 2027, By Drug Class (US$ Mn)

Table 2.            South and Central America Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)

Table 3.            South and Central America Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 4.            South and Central America Gastrointestinal Drugs Market Revenue and Forecasts To 2027, By Distribution Channel (US$ Mn)

Table 5.            South and Central America: Gastrointestinal Drugs Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 6.            South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.            South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 8.            South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.            Brazil: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

Table 10.          Brazil: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 11.          Brazil: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.          Brazil: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Argentina: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

Table 14.          Argentina: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 15.          Argentina: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 16.          Argentina: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 17.          Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic – Revenue and Forecast to 2027 (USD Million)

Table 18.          Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration – Revenue and Forecast to 2027  (USD Million)

Table 19.          Rest of South and Central America: Gastrointestinal Drugs Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 20.          Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027  (USD Million)

Table 21.          Glossary of Terms, Gastrointestinal Drugs Market

LIST OF FIGURES

Figure 1.           Gastrointestinal Drugs Market Segmentation

Figure 2.           South and Central America Gastrointestinal Drugs Market Overview

Figure 3.           Acid Neutralizers Segment Held Largest Share of Product in Gastrointestinal Drugs Market

Figure 4.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           South and Central America Gastrointestinal Drugs Market - Leading Country Markets (US$ Mn)

Figure 6.           Gastrointestinal Drugs Market - South and Central America PEST Analysis

Figure 7.           Gastrointestinal Drugs Market Impact Analysis of Drivers and Restraint

Figure 8.           South and Central America Gastrointestinal Drugs market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           South and Central America Gastrointestinal Drugs Market, By Drug Class 2019 & 2027 (%)

Figure 10.        South and Central America Acid Neutralizers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        South and Central America Antidiarrheal and Laxatives Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        South and Central America Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        South and Central America Antiemetic and Antinauseants Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        South and Central America Biologics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        South and Central America Anti-Inflammatory Drugs Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        South and Central America Gastrointestinal Drugs Market, by Route of Administration 2019 & 2027 (%)

Figure 17.        South and Central America Oral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        South and Central America Parenteral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        South and Central America Gastrointestinal Drugs Market, by Application 2019 & 2027 (%)

Figure 20.        South and Central America Inflammatory Ulcerative Colitis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        South and Central America Crohn's Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        South and Central America Irritable Bowel Syndrome Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.        South and Central America Gastroenteritis Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24.        South and Central America Celiac Disease Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.        South and Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.        South and Central America Gastrointestinal Drugs Market, by Distribution Channel 2019 & 2027 (%)

Figure 27.        South and Central America Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 28.        South and Central America Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.        South and Central America Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.        South and Central America: Gastrointestinal Drugs Market , by Key Country – Revenue (2019) (USD Million)

Figure 31.        South and Central America: Gastrointestinal Drugs Market, Revenue and Forecast to 2027 (USD Million)

Figure 32.        South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)

Figure 33.        Brazil: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 34.        Argentina: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Rest of South and Central America: Gastrointestinal Drugs Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Impact of COVID-19 Pandemic on Gastrointestinal Drugs market in Rest of the World

1. Celltrion Healthcare Co.,Ltd
2. GlaxoSmithKline plc
3. Johnson and Johnson Services, Inc.
4. AstraZeneca
5. Takeda Pharmaceutical Company Limited

• It provides understanding of the South and Central America, gastrointestinal drugs market landscape and identifies gastrointestinal drugs market segments that are most likely to guarantee a strong return.
• It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the South and Central America gastrointestinal drugs market.
• It helps efficiently plan merger and acquisition, and partnership deals in the gastrointestinal drugs market by identifying market segments with the most promising probable sales
• It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of gastrointestinal drugs market performance of various segments pertaining to the South and Central America gastrointestinal drugs market.
• It provides gastrointestinal drugs market revenue forecast of the market based on various segments for the period from 2019 to 2027.